Purpose
5-Fluorouracil (5-Fu) is used as a conventional chemotherapy drug in chemotherapy for patients with advanced colorectal cancer, but many patients still suffer from treatment failure due to 5-Fu resistance. Emerging observations revealed the important role of chemokine (C-X-C motif) ligand 13 (CXCL-13) in tumor microenvironment and its relationship with prognosis in patients with colorectal cancer. This study is designed to reveal the important role of CXCL-13 in causing colorectal cancer resistance to 5-Fu.
Materials and Methods
CXCL-13 levels of patient's serum or cell culture supernatants were measured separately by enzyme-linked immunosorbent assay. In cell assays, cell viability is detected by Cell Counting Kit-8. Therefore, the recombinant human CXCL-13 was used to simulate its high expression in cells while its antibody and siRNA were used to reduce CXCL-13 expression in cells.
Results
In this study, we demonstrated that CXCL-13 is associated with 5-Fu resistance by culture medium exchange experiments and cytokine arrays of colorectal cancer resistant and nonresistant cells. Clinical studies showed that CXCL-13 is highly expressed in the serum of 5-Fu–resistant patients. High levels of serum CXCL-13 also predict a worse clinical outcome. The addition of recombinant CXCL-13 cytokine resulted in 5-Fu resistance, while its antibody overcame 5-Fu resistance, and knockdown of CXCL-13 expression by siRNA also reduced 5-Fu resistance, which can be saved by added recombination CXCL-13.
Conclusion
These results not only identify a CXCL-13 mediated 5-Fu resistance mechanism but also provide a novel target for 5-Fu–resistant colorectal cancer in prevention and treatment strategies.
Citations
Citations to this article as recorded by
Nucleotide metabolism-associated drug resistance gene NDUFA4L2 promotes colon cancer progression and 5-FU resistance Hongxin HE, Shiyao ZHENG, Shangkun JIN, Weijie HUANG, Enhao WEI, Shen GUAN, Chunkang YANG Scientific Reports.2025;[Epub] CrossRef
Mechanism of 5-fluorouracil induced resistance and role of piperine and curcumin as chemo-sensitizers in colon cancer Dorothy Bhattacharjya, Nageswaran Sivalingam Naunyn-Schmiedeberg's Archives of Pharmacology.2024; 397(11): 8445. CrossRef
The combination of SHP099 inhibits the malignant biological behavior of L-OHP/5-FU-resistant colorectal cancer cells by regulating energy metabolism reprogramming Meilian Wang, Kun Yu, Wen Fu, Lihong Yang Biochemical and Biophysical Research Communications.2024; 728: 150262. CrossRef
Serum CXCL13 as a Novel Biomarker in Oral Squamous Cell Carcinoma Shin Tojo, Koh‐ichi Nakashiro, Nobuyuki Kuribayashi, Daisuke Uchida Cancer Medicine.2024;[Epub] CrossRef
The potential of kaempferol in digestive system tumors: recent advances and mechanistic insights Xunxing Hao, Meng Ding, Chenyu Chi, Xiaodong Xu, Xiaoyu Zhang, Mingzhe Hu Discover Oncology.2024;[Epub] CrossRef
Identification of a tissue resident memory CD8 T cell-related risk score signature for colorectal cancer, the association with TME landscapes and therapeutic responses Jiazheng Li, Chao Yang, Yongbin Zheng Frontiers in Genetics.2023;[Epub] CrossRef
Prognostic Significance of the CXCLs and Its Impact on the Immune Microenvironment in Ovarian Cancer Cairu Gu, Xifeng Xiong, Wei Liu, Elisa Belluzzi Disease Markers.2023; 2023: 1. CrossRef
TIMP-2 as a predictive biomarker in 5-Fu-resistant colorectal cancer Yaoqing Li, Chuchu Xu, Renjun Zhu, Liyijing Shen, Gengyuan Hu, Kelong Tao, Feng Tao, Zengxin Lu, Guolin Zhang Journal of Cancer Research and Clinical Oncology.2023; 149(10): 7235. CrossRef
Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypes Katharine Yu, Amrita Basu, Christina Yau, Denise M. Wolf, Hani Goodarzi, Sourav Bandyopadhyay, James E. Korkola, Gillian L. Hirst, Smita Asare, Angela DeMichele, Nola Hylton, Douglas Yee, Laura Esserman, Laura van ‘t Veer, Marina Sirota Frontiers in Oncology.2023;[Epub] CrossRef
Host Transcriptional Regulatory Genes and Microbiome Networks Crosstalk through Immune Receptors Establishing Normal and Tumor Multiomics Metafirm of the Oral-Gut-Lung Axis Beatriz Andrea Otálora-Otálora, Juan Javier López-Rivera, Claudia Aristizábal-Guzmán, Mario Arturo Isaza-Ruget, Carlos Arturo Álvarez-Moreno International Journal of Molecular Sciences.2023; 24(23): 16638. CrossRef
Expansion of CD4+ cytotoxic T lymphocytes with specific gene expression patterns may contribute to suppression of tumor immunity in oral squamous cell carcinoma: single-cell analysis and in vitro experiments Hu Chen, Junsei Sameshima, Shiho Yokomizo, Tomoki Sueyoshi, Haruki Nagano, Yuka Miyahara, Taiki Sakamoto, Shinsuke Fujii, Tamotsu Kiyoshima, Thomas Guy, Seiji Nakamura, Masafumi Moriyama, Naoki Kaneko, Shintaro Kawano Frontiers in Immunology.2023;[Epub] CrossRef
Identification of Key Gene Targets for Sensitizing Colorectal Cancer to Chemoradiation: an Integrative Network Analysis on Multiple Transcriptomics Data Hamed Manoochehri, Akram Jalali, Hamid Tanzadehpanah, Amir Taherkhani, Massoud Saidijam Journal of Gastrointestinal Cancer.2022; 53(3): 649. CrossRef
Exosomes-mediated tumor treatment: One body plays multiple roles Na Xu, Ranran Guo, Xiaotong Yang, Ning Li, Jia Yu, Peng Zhang Asian Journal of Pharmaceutical Sciences.2022; 17(3): 385. CrossRef
Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer Ching-Hung Hsieh, Cheng-Zhe Jian, Liang-In Lin, Guan-Sian Low, Ping-Yun Ou, Chiun Hsu, Da-Liang Ou Cancers.2022; 14(2): 294. CrossRef
Comprehensive analysis of the expression and significance of CXCLs in human diffuse large B-cell lymphoma Xiaonan Zhou, Shizhu Guo, Yonghong Shi Scientific Reports.2022;[Epub] CrossRef
Kaempferol Can Reverse the 5-Fu Resistance of Colorectal Cancer Cells by Inhibiting PKM2-Mediated Glycolysis Haili Wu, Jin’e Du, Chenglu Li, Hanqing Li, Huiqin Guo, Zhuoyu Li International Journal of Molecular Sciences.2022; 23(7): 3544. CrossRef
Chemokines and chemokine receptors in colorectal cancer; multifarious roles and clinical impact Maria Braoudaki, Mohammed Saqif Ahmad, Denis Mustafov, Sara Seriah, Mohammad Naseem Siddiqui, Shoib Sarwar Siddiqui Seminars in Cancer Biology.2022; 86: 436. CrossRef
Bioinformatics Analysis of Prognostic Significance and Immune Characteristics of CXC Chemokine Family in Patients with Lung Adenocarcinoma Dachen Bian, Yanhua Chen, Ahmed Faeq Hussein Computational and Mathematical Methods in Medicine.2022; 2022: 1. CrossRef
Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer Qian Zou, Xue Lei, Aijing Xu, Ziqi Li, Qinglian He, Xiujuan Huang, Guangxian Xu, Faqing Tian, Yuanlin Ding, Wei Zhu Frontiers in Immunology.2022;[Epub] CrossRef
CXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer Binhan Wang, Manni Wang, Danyi Ao, Xiawei Wei Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2022; 1877(5): 188799. CrossRef
A novel oxidative stress- and ferroptosis-related gene prognostic signature for distinguishing cold and hot tumors in colorectal cancer Xu Wang, Yuanmin Xu, Longfei Dai, Zhen Yu, Ming Wang, Shixin Chan, Rui Sun, Qijun Han, Jiajie Chen, Xiaomin Zuo, Zhenglin Wang, Xianyu Hu, Yang Yang, Hu Zhao, Kongwang Hu, Huabing Zhang, Wei Chen Frontiers in Immunology.2022;[Epub] CrossRef
Identification of necroptosis-related subtypes, development of a novel signature, and characterization of immune infiltration in colorectal cancer Mengyu Sun, Xiaoyu Ji, Meng Xie, Xiaoping Chen, Bixiang Zhang, Xiangyuan Luo, Yangyang Feng, Danfei Liu, Yijun Wang, Yiwei Li, Bifeng Liu, Limin Xia, Wenjie Huang Frontiers in Immunology.2022;[Epub] CrossRef
Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment Shamin Azwar, Heng Fong Seow, Maha Abdullah, Mohd Faisal Jabar, Norhafizah Mohtarrudin Biology.2021; 10(9): 854. CrossRef
CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer Sipei Nie, Yicong Wan, Hui Wang, Jinhui Liu, Jing Yang, Rui Sun, Huangyang Meng, Xiaolin Ma, Yi Jiang, Wenjun Cheng Journal of Ovarian Research.2021;[Epub] CrossRef
The CXCL Family Contributes to Immunosuppressive Microenvironment in Gliomas and Assists in Gliomas Chemotherapy Zeyu Wang, Yuze Liu, Yuyao Mo, Hao Zhang, Ziyu Dai, Xun Zhang, Weijie Ye, Hui Cao, Zhixiong Liu, Quan Cheng Frontiers in Immunology.2021;[Epub] CrossRef
Multifaceted roles of CCL20 (C-C motif chemokine ligand 20): mechanisms and communication networks in breast cancer progression Louis Boafo Kwantwi, Shujing Wang, Youjing Sheng, Qiang Wu Bioengineered.2021; 12(1): 6923. CrossRef
CXCL13 in Cancer and Other Diseases: Biological Functions, Clinical Significance, and Therapeutic Opportunities San-Hui Gao, Sheng-Zhi Liu, Gui-Zhen Wang, Guang-Biao Zhou Life.2021; 11(12): 1282. CrossRef
Therapeutic Influence on Important Targets Associated with Chronic Inflammation and Oxidative Stress in Cancer Treatment Margarita Neganova, Junqi Liu, Yulia Aleksandrova, Sergey Klochkov, Ruitai Fan Cancers.2021; 13(23): 6062. CrossRef
Chemoresistance Mechanisms in Colon Cancer: Focus on Conventional Chemotherapy Klara Mladenić , Mirela Sedić Clinical Cancer Drugs.2021; 8(2): 67. CrossRef
Igor Tsaur, Anika Noack, Jasmina Makarevic, Elsie Oppermann, Ana Maria Waaga-Gasser, Martin Gasser, Hendrik Borgmann, Tanja Huesch, Kilian M. Gust, Michael Reiter, David Schilling, Georg Bartsch, Axel Haferkamp, Roman A. Blaheta
Cancer Res Treat. 2015;47(2):306-312. Published online October 13, 2014
Purpose Prostate specific antigen is not reliable in diagnosing prostate cancer (PCa), making the identification of novel, precise diagnostic biomarkers important. Since chemokines are associated with more aggressive disease and poor prognosis in diverse malignancies, we aimed to investigate the diagnostic relevance of chemokines in PCa. Materials and Methods Preoperative and early postoperative serum samples were obtained from 39 consecutive PCa patients undergoing radical prostatectomy. Serum from 15 healthy volunteers served as controls. Concentrations of CXCL12, CXCL13, CX3CL1, CCL2, CCL5, and CCL20 were measured in serum by Luminex. The expression activity of CXCR3, CXCR4, CXCR5, CXCR7, CXCL12, CXCL13, CX3CR1, CXCL1, CCR2, CCR5, CCR6, CCR7, CCL2, and CCL5 mRNA was assessed in tumor and adjacent normal tissue of prostatectomy specimens by quantitative real-time polymerase chain reaction. The associations of these chemokines with clinical and histological parameters were tested. Results The gene expression activity of CCL2 and CCR6 was significantly higher in tumor tissue compared to adjacent normal tissue. CCL2 was also significantly higher in the blood samples of PCa patients, compared to controls. CCL5, CCL20, and CX3CL1 were lower in patient serum, compared to controls. CCR2 tissue mRNA was negatively correlated with the Gleason score and grading. Conclusion Chemokines are significantly modified during tumorigenesis of PCa, and CCL2 is a promising diagnostic biomarker.
Citations
Citations to this article as recorded by
Single-cell RNA sequencing reveals intratumoral heterogeneity and potential mechanisms of malignant progression in prostate cancer with perineural invasion Bao Zhang, Shenghan Wang, Zhichao Fu, Qiang Gao, Lin Yang, Zhentao Lei, Yuqiang Shi, Kai Le, Jie Xiong, Siyao Liu, Jiali Zhang, Junyan Su, Jing Chen, Mengyuan Liu, Beifang Niu Frontiers in Genetics.2023;[Epub] CrossRef
Osteoid cell-derived chemokines drive bone-metastatic prostate cancer Catherine S. Johnson, Leah M. Cook Frontiers in Oncology.2023;[Epub] CrossRef
Macrophages as a Therapeutic Target in Metastatic Prostate Cancer: A Way to Overcome Immunotherapy Resistance? Clara Martori, Lidia Sanchez-Moral, Tony Paul, Juan Carlos Pardo, Albert Font, Vicenç Ruiz de Porras, Maria-Rosa Sarrias Cancers.2022; 14(2): 440. CrossRef
Plasma Chemokine C-C Motif Ligand 2 as a Potential Biomarker for Prostate Cancer Martin Lund, Torben B Pedersen, Søren Feddersen, Louise D Østergaard, Charlotte A Poulsen, Christian Enggaard, Mads H Poulsen, Lars Lund Research and Reports in Urology.2022; Volume 14: 33. CrossRef
Potential PET tracers for imaging of tumor-associated macrophages Bruna Fernandes, Paula Kopschina Feltes, Carolina Luft, Luiza Reali Nazario, Cristina Maria Moriguchi Jeckel, Ines F. Antunes, Philip H. Elsinga, Erik F. J. de Vries EJNMMI Radiopharmacy and Chemistry.2022;[Epub] CrossRef
Usefulness of serum CCL2 as prognostic biomarker in prostate cancer: a long-term follow-up study Hiroaki Iwamoto, Kouji Izumi, Ryunosuke Nakagawa, Ren Toriumi, Shuhei Aoyama, Takafumi Shimada, Hiroshi Kano, Tomoyuki Makino, Suguru Kadomoto, Hiroshi Yaegashi, Shohei Kawaguchi, Takahiro Nohara, Kazuyoshi Shigehara, Yoshifumi Kadono, Atsushi Mizokami Japanese Journal of Clinical Oncology.2022;[Epub] CrossRef
Potential mechanisms ofPyrrosiae Foliumin treating prostate cancer based on network pharmacology and molecular docking Wen-Hua Guo, Kun Zhang, Lu-Hong Yang Drug Development and Industrial Pharmacy.2022; 48(5): 189. CrossRef
White adipose tissue-derived factors and prostate cancer progression: mechanisms and targets for interventions Achinto Saha, Jill Hamilton-Reeves, John DiGiovanni Cancer and Metastasis Reviews.2022; 41(3): 649. CrossRef
Does C-C Motif Chemokine Ligand 2 (CCL2) Link Obesity to a Pro-Inflammatory State? Sebastian Dommel, Matthias Blüher International Journal of Molecular Sciences.2021; 22(3): 1500. CrossRef
Characterization of the perioperative changes of exosomal immune-related cytokines induced by prostatectomy in early-stage prostate cancer patients Mónica Macías, Ángel García-Cortés, Marcos Torres, Javier Ancizu-Marckert, Juan Ignacio Pascual, Fernando Díez-Caballero, José Enrique Robles, David Rosell, Bernardino Miñana, Beatriz Mateos, Daniel Ajona, Rodrigo Sánchez-Bayona, Oihane Bedialauneta, Susa Cytokine.2021; 141: 155471. CrossRef
Research Trends and Regulation of CCL5 in Prostate Cancer Renlun Huang, Lang Guo, Menghan Gao, Jing Li, Songtao Xiang OncoTargets and Therapy.2021; Volume 14: 1417. CrossRef
Expression of CCL2/CCR2 signaling proteins in breast carcinoma cells is associated with invasive progression Wei Bin Fang, Diana Sofia Acevedo, Curtis Smart, Brandon Zinda, Nadia Alissa, Kyle Warren, Garth Fraga, Li-Ching Huang, Yu Shyr, Wei Li, Lu Xie, Vincent Staggs, Yan Hong, Fariba Behbod, Nikki Cheng Scientific Reports.2021;[Epub] CrossRef
CCL2 (C-C Motif Chemokine Ligand 2) Biomarker Responses in Central Versus Peripheral Compartments After Focal Cerebral Ischemia Jingfei Shi, Wenlu Li, Fang Zhang, Ji Hyun Park, Hong An, Shuzhen Guo, Yunxia Duan, Di Wu, Kazuhide Hayakawa, Eng H. Lo, Xunming Ji Stroke.2021; 52(11): 3670. CrossRef
On the Road to Accurate Protein Biomarkers in Prostate Cancer Diagnosis and Prognosis: Current Status and Future Advances Yiwu Yan, Su Yeon Yeon, Chen Qian, Sungyong You, Wei Yang International Journal of Molecular Sciences.2021; 22(24): 13537. CrossRef
Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting Tetiana Hourani, James A. Holden, Wenyi Li, Jason C. Lenzo, Sara Hadjigol, Neil M. O’Brien-Simpson Frontiers in Oncology.2021;[Epub] CrossRef
Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones? Nathan Karin Cancers.2021; 13(24): 6317. CrossRef
Genetically predicted levels of circulating cytokines and prostate cancer risk: A Mendelian randomization study Xiaohui Sun, Ding Ye, Lingbin Du, Yu Qian, Xia Jiang, Yingying Mao International Journal of Cancer.2020; 147(9): 2469. CrossRef
SFMBT2-Mediated Infiltration of Preadipocytes and TAMs in Prostate Cancer Jungsug Gwak, Hayan Jeong, Kwanghyun Lee, Jee Yoon Shin, Taejun Sim, Jungtae Na, Jongchan Kim, Bong-Gun Ju Cancers.2020; 12(9): 2718. CrossRef
The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative Nathan Karin Frontiers in Immunology.2020;[Epub] CrossRef
Can Blood-Circulating Factors Unveil and Delay Your Biological Aging? Natalia Rybtsova, Tatiana Berezina, Alexander Kagansky, Stanislav Rybtsov Biomedicines.2020; 8(12): 615. CrossRef
Prostate cancer and inflammation: A new molecular imaging challenge in the era of personalized medicine Orazio Schillaci, Manuel Scimeca, Donata Trivigno, Agostino Chiaravalloti, Simone Facchetti, Lucia Anemona, Rita Bonfiglio, Giuseppe Santeusanio, Virginia Tancredi, Elena Bonanno, Nicoletta Urbano, Alessandro Mauriello Nuclear Medicine and Biology.2019; 68-69: 66. CrossRef
Role of ALDH1A1 and HTRA2 expression to CCL2/CCR2 mediated breast cancer cell growth and invasion Qingting Hu, Megan Myers, Wei Fang, Min Yao, Gage Brummer, Justin Hawj, Curtis Smart, Cory Berkland, Nikki Cheng Biology Open.2019;[Epub] CrossRef
Serum levels of the chemokine CCL2 are elevated in malignant pleural mesothelioma patients Takumi Kishimoto, Nobukazu Fujimoto, Takeshi Ebara, Toyonori Omori, Tetsuya Oguri, Akio Niimi, Takako Yokoyama, Munehiro Kato, Ikuji Usami, Masayuki Nishio, Kosho Yoshikawa, Takeshi Tokuyama, Mouka Tamura, Yoshifumi Yokoyama, Ken Tsuboi, Yoichi Matsuo, Ji BMC Cancer.2019;[Epub] CrossRef
RETRACTED: Elevated Expression Levels of PC3-Secreted Microprotein (PSMP) in Prostate Cancer Associated With Increased Xenograft Growth and Modification of Immune-Related Microenvironment Xiaolei Pei, Danfeng Zheng, Shaoping She, Zhiwei Fang, Shiying Zhang, Hao Hu, Kexin Xu, Ying Wang Frontiers in Oncology.2019;[Epub] CrossRef
More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis Martha Gschwandtner, Rupert Derler, Kim S. Midwood Frontiers in Immunology.2019;[Epub] CrossRef
Differential expression of E-cadherin and P-cadherin in pT3 prostate cancer: correlation with clinical and pathological features Catarina Ferreira, João Lobo, Luís Antunes, Paula Lopes, Carmen Jerónimo, Rui Henrique Virchows Archiv.2018; 473(4): 443. CrossRef
Analysis of Argonaute Complex Bound mRNAs in DU145 Prostate Carcinoma Cells Reveals New miRNA Target Genes Jaroslaw Szczyrba, Volker Jung, Michaela Beitzinger, Elke Nolte, Sven Wach, Martin Hart, Sandra Sapich, Marc Wiesehöfer, Helge Taubert, Gunther Wennemuth, Norbert Eichner, Thomas Stempfl, Bernd Wullich, Gunter Meister, Friedrich A. Grässer Prostate Cancer.2017; 2017: 1. CrossRef
Insulin secretagogue use and circulating inflammatory C–C chemokine levels in breast cancer patients Zachary A.P. Wintrob, Jeffrey P. Hammel, George K. Nimako, Zahra S. Fayazi, Dan P. Gaile, Alan Forrest, Alice C. Ceacareanu Data in Brief.2017; 11: 391. CrossRef
Data report on inflammatory C–C chemokines among insulin-using women with diabetes mellitus and breast cancer Zachary A.P. Wintrob, Jeffrey P. Hammel, George K. Nimako, Zahra S. Fayazi, Dan P. Gaile, Erin E. Davis, Alan Forrest, Alice C. Ceacareanu Data in Brief.2017; 11: 446. CrossRef
Activity and Functions of Tumor-associated Macrophages in Prostate Carcinogenesis Matteo Santoni, Liang Cheng, Alessandro Conti, Cinzia Mariani, Antonio Lopez-Beltran, Rodolfo Montironi, Nicola Battelli European Urology Supplements.2017; 16(12): 301. CrossRef
Association of mast cell infiltration with gastric cancer progression Bei Zhong, Yu Li, Xiaodong Liu, Dongsheng Wang Oncology Letters.2017;[Epub] CrossRef
Syndecan-1 up-regulates microRNA-331-3p and mediates epithelial-to-mesenchymal transition in prostate cancer Tomomi Fujii, Keiji Shimada, Yoshihiro Tatsumi, Nobumichi Tanaka, Kiyohide Fujimoto, Noboru Konishi Molecular Carcinogenesis.2016; 55(9): 1378. CrossRef
Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review Alessandro Sciarra, Alessandro Gentilucci, Stefano Salciccia, Federico Pierella, Flavio Del Bianco, Vincenzo Gentile, Ida Silvestri, Susanna Cattarino Journal of Inflammation.2016;[Epub] CrossRef
Tailored chemokine receptor modification improves homing of adoptive therapy T cells in a spontaneous tumor model Stefano Garetto, Claudia Sardi, Elisa Martini, Giuliana Roselli, Diego Morone, Roberta Angioni, Beatrice Claudia Cianciotti, Anna Elisa Trovato, Davide Giuseppe Franchina, Giovanni Francesco Castino, Debora Vignali, Marco Erreni, Federica Marchesi, Cristi Oncotarget.2016; 7(28): 43010. CrossRef
Inflammation and prostate cancer: friends or foe? Gianluigi Taverna, Elisa Pedretti, Giuseppe Di Caro, Elena Monica Borroni, Federica Marchesi, Fabio Grizzi Inflammation Research.2015; 64(5): 275. CrossRef
CCL2 promotes integrin-mediated adhesion of prostate cancer cells in vitro Igor Tsaur, Jochen Rutz, Jasmina Makarević, Eva Juengel, Kilian M. Gust, Hendrik Borgmann, David Schilling, Karen Nelson, Axel Haferkamp, Georg Bartsch, Roman A. Blaheta World Journal of Urology.2015; 33(7): 1051. CrossRef
sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patients Igor Tsaur, Kristina Thurn, Eva Juengel, Kilian M. Gust, Hendrik Borgmann, Rene Mager, Georg Bartsch, Elsie Oppermann, Hanns Ackermann, Karen Nelson, Axel Haferkamp, Roman A. Blaheta Journal of Experimental & Clinical Cancer Research.2015;[Epub] CrossRef
The Role of Biomarkers and Genetics in the Diagnosis of Prostate Cancer Firas Abdollah, Deepansh Dalela, Michael C. Haffner, Zoran Culig, Jack Schalken European Urology Focus.2015; 1(2): 99. CrossRef